Cohort Company News - MedTech Innovator

Vynca and Cerner Empower Patients and Clinicians to Honor End-Of-Life Care Decisions

DateSep 22 2020

Vynca, a national leader in advance care planning solutions, today announced a relationship with Cerner Corporation (Nasdaq: CERN), a global health care technology company, to help individuals and their families, caregivers and clinicians navigate the complex advance care planning process to ensure future care preferences are honored.

Israeli pain monitoring co Medasense raises $18m

DateSep 22 2020

The company's technology uses a multi-parametric sensor platform and advanced AI algorithms to convert complicated data into a patient's "Signature of Pain."

Osso VR raises $14 million to bring virtual reality to surgical and medical device training

DateSep 21 2020

Virtual reality tools like those on offer from Osso VR have been raising investor dollars at a rapid clip, and now the Palo Alto, California-based virtual reality distribution platform joins their ranks with a $14 million round of financing.

Avisi Technologies Eyes Goal of Human Trials With $1M National Science Foundation Grant

DateSep 21 2020

The Pennovation-based startup that makes an ocular implant to treat glaucoma also raised half a million in seed funding.

Exclusive: First full at-home COVID-19 test (featuring Gauss)

DateSep 16 2020

Gauss, a computer vision startup, and Cellex, a biotech company that works on diagnostics, are announcing the first rapid COVID-19 test that can be fully performed by people at home without involving a laboratory.

Wireless EEG for Fast Prep and Easy Use: Q&A with Aswin Gunasekar, CEO of Zeto

DateSep 15 2020

Zeto Inc. a medtech startup based in California, has developed a new EEG device that sits on the head like a bicycle helmet. The headset does not require gels or pastes to function, and can transmit data wirelessly.

7D Surgical’s Largest Financing Round to Bolster Product Development, Expansion Plans

DateSep 15 2020

The spine device company aims to use the capital for product development, international expansion and operational growth.

Fibralign Announces CE Mark Approval for BioBridge

DateSep 14 2020

Fibralign Corp., a Stanford spin-out and developer of therapeutic biomedical devices, today announced that it has received CE mark for its first product, the BioBridge® Collagen Matrix.

PhotoniCare Announces More Than $7M in Funding for Commercial Expansion of First-In-Class Ear Imaging Technology

DateSep 03 2020

PhotoniCare, Inc., a company dedicated to revolutionizing healthcare by providing physicians with better diagnostic tools, today announced an oversubscribed $5.2 million Series A financing led by i2E Management Company Inc., with co-investment from OSF Ventures, Sony Innovation Fund, and Dreampact Ventures.

Miracor Medical Raises €24M in Funding

DateSep 02 2020

Miracor Medical SA, an Awans, Belgium-based provider of innovative solutions for the treatment of severe cardiac diseases, closed a €24M Series E round of financing.

ODS Medical, Inc. closes a new financing round to further support product development diversification of applications

DateSep 01 2020

ODS Medical, Inc., a Montreal based medical technology company, is pleased to announce a new financing round to support product engineering and regulatory work.

CoapTech Raises $7M in Series B Funding Led by Hunniwell

DateAug 28 2020

CoapTech, a leading medical device start-up pioneering the world’s first and only ultrasound-based feeding tube placement system, announced the closing of a Series B investment of $7 million led by medical device venture capital firm Hunniwell Lake Ventures. They will use funds to commercialize the First FDA-cleared, Ultrasound-based system for Feeding Tube Placement.

Sidekick Health wins the eHealth Award 2020

DateAug 25 2020

The annual award was open for startups from all the Nordic countries for the first time this year. This year, Icelandic health company Sidekick Health ended up as winners after having been one of three finalists together with Swedish-Norwegian Boneproxand Swedish Cuviva.

LensGen® Closes $10 Million Financing and Welcomes James V. Mazzo to its Board of Directors

DateAug 20 2020

LensGen, Inc., an ophthalmic medical device company and developer of Juvene®, a disruptive fluid-optic intraocular lens (IOL) for cataract and presbyopia treatment, announces the initial Closing of a $10 million of the $20 million Bridge Financing. The company is also pleased to announce the election of James (Jim) Mazzo to its Board of Directors.

Money Moves: 3 life science and health IT companies raise funds — and one goes public (featuring Strados Labs)

DateAug 20 2020

Strados Labs has been awarded a National Science Foundation (NSF)Phase I Small Business Innovation Research grant for nearly $225,000 to conduct research on its wearable platform for remote respiratory monitoring.

Sentien Biotechnologies Announces Open IND in Phase 1/2 Trial of SBI-101 for Patients with COVID-19

DateAug 18 2020

Sentien Biotechnologies, Inc., a clinical-stage biotechnology company developing novel approaches to cell therapy, today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s Investigational New Drug (IND) application for the evaluation of Sentien’s lead asset, SBI-101, for the treatment of severe COVID-19.

Oncodisc, Inc. Awarded Competitive Grant from the National Science Foundation to Develop Cancer Technology

DateAug 06 2020

Oncodisc, Inc. today announced that it is the recipient of a competitive National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant award.

Discover the Power of VUNO’s AI Solutions at ECR 2020

DateJul 14 2020

VUNO Inc., South Korean artificial intelligence (AI) developer announced that it will attend the European Congress of Radiology 2020 (ECR 2020) to be held from July 15 to July 19, 2020 to showcase the power of its flagship AI radiology solutions that have recently received the CE mark

HD Medical Awarded FDA Clearance For HD Steth

DateJul 14 2020

HD Medical, Inc. of Silicon Valley today announces that its flagship product, HD Steth, has received FDA clearance for all three product classification codes of DQD, DQC and DPS for Electronic Stethoscope, Phonocardiograph and Electrocardiograph combined into one device. HD Steth utilizes cutting-edge AI technology to enable clinicians to perform advanced cardiac evaluation at the point-of-care to save time and lives.

Forest Devices Launches Collaboration With Alberta Health Services

DateJun 30 2020

Medical technology pioneer Forest Devices, Inc. (FDI) today announced a commitment to improve healthcare delivery for stroke patients in Alberta, forming a collaboration with Alberta Health Services (AHS) to evaluate and test technologies that can improve patient outcomes and health system performance by empowering emergency first responders to make informed decisions regarding care for stroke patients.